TARO TO INTRODUCE ONE DOZEN "NICHE" OTCs BY END OF 1994
This article was originally published in The Tan Sheet
Executive Summary
TARO TO INTRODUCE ONE DOZEN "NICHE" OTCs BY END OF 1994 in the U.S. and Canada that will be imported from the firm's manufacturing facilities in Israel, Taro Senior VP and Chief Operating Officer Peter Giallorenzo told analysts at the recent Kidder, Peabody Healthcare Conference in New York City. Taro said the majority of the OTCs will be marketed in the cough/cold and analgesic categories in both topical and liquid forms. To date, the company's primary focus has been on products in the dermatologic category.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning